Bleomycin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00290 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | cauda equina neoplasm | KG + DL |
| 2 | adult astrocytic tumour | KG + DL |
| 3 | reticulum cell sarcoma | KG + DL |
| 4 | primary pulmonary lymphoma | KG + DL |
| 5 | pulmonary blastoma | KG + DL |
| 6 | well-differentiated fetal adenocarcinoma of the lung | KG + DL |
| 7 | small cell lung carcinoma | KG + DL |
| 8 | interdigitating dendritic cell sarcoma | KG + DL |
| 9 | acute lymphoblastic/lymphocytic leukemia | KG + DL |
| 10 | astrocytoma (excluding glioblastoma) | KG + DL |
| 11 | small intestinal Burkitt lymphoma | KG + DL |
| 12 | subcutaneous panniculitis-like T-cell lymphoma | KG + DL |
| 13 | colon adenocarcinoma | KG + DL |
| 14 | extragonadal teratoma | KG + DL |
| 15 | hairy cell leukemia variant | KG + DL |
| 16 | ovarian lymphoma | KG + DL |
| 17 | nasal cavity lymphoma | KG + DL |
| 18 | AIDS-related primary central nervous system lymphoma | KG + DL |
| 19 | progressive transformation of germinal centers | KG + DL |
| 20 | composite lymphoma | KG + DL |
| 21 | refractory hairy cell leukemia | KG + DL |
| 22 | teratoma | KG + DL |
| 23 | mature teratoma | KG + DL |
| 24 | small intestinal mucosa-associated lymphoid tissue lymphoma | KG + DL |
| 25 | breast mucosa-associated lymphoid tissue lymphoma | KG + DL |
| 26 | head and neck carcinoma | KG + DL |
| 27 | tonsillar lymphoma | KG + DL |
| 28 | gastric mucosa-associated lymphoid tissue lymphoma | KG + DL |
| 29 | follicular lymphoma, susceptibility to, 1 | KG + DL |
| 30 | thyroid gland mucosa-associated lymphoid tissue lymphoma | KG + DL |
| 31 | pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma | KG + DL |
| 32 | chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation | KG + DL |
| 33 | malignant breast phyllodes tumor | KG + DL |
| 34 | soft palate cancer | KG + DL |
| 35 | malignant neoplasm of acoustic nerve | KG + DL |
| 36 | vestibule of mouth cancer | KG + DL |
| 37 | lung lymphoma | KG + DL |
| 38 | retromolar area cancer | KG + DL |
| 39 | skull base chordoma | KG + DL |
| 40 | paranasal sinus cancer | KG + DL |
| 41 | breast lymphoma | KG + DL |
| 42 | uveal cancer | KG + DL |
| 43 | inner ear cancer | KG + DL |
| 44 | methotrexate-associated lymphoproliferative disorders | KG + DL |
| 45 | B-cell lymphoma, unclassifiable, with features intermediate between diffuse large b-cell lymphoma and classical Hodgkin lymphoma | KG + DL |
| 46 | middle ear cancer | KG + DL |
| 47 | ureteral lymphoma | KG + DL |
| 48 | tracheal lymphoma | KG + DL |
| 49 | bladder lymphoma | KG + DL |
| 50 | lymph node cancer | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.